Evidence map›Paper›PMID 39840009›Full record

ArticleFrontiers in neuroscience2024

Preliminary evaluation of the FastCAP for users of the Nurotron cochlear implant.

Xue-Ying Yang, Sui Huang, Qian-Jie Fu, John Galvin, Bing Chen, Ji-Sheng Liu, Duo-Duo Tao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xue-Ying YangThe First Affiliated Hospital of Soochow University, Suzhou, China.
Sui HuangZhejiang Key Laboratory of Neuroelectronic and Brain Computer Interface Technology, Hangzhou, China.
Qian-Jie FuDavid Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.
John GalvinHouse Institute Foundation, Los Angeles, CA, United States.
Bing ChenEye and ENT Hospital, Fudan University, Shanghai, China.
Ji-Sheng LiuThe First Affiliated Hospital of Soochow University, Suzhou, China.
Duo-Duo TaoThe First Affiliated Hospital of Soochow University, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Electrically evoked compound action potential (ECAP) can be used to measure the auditory nerve's response to electrical stimulation in cochlear implant (CI) users. In the Nurotron CI system, extracting the ECAP waveform from the stimulus artifact is time-consuming. Method: We developed a new paradigm ("FastCAP") for use with Nurotron CI devices. In electrically evoked compound action potential in fast mode (FastCAP), N recordings are averaged directly on the CI hardware before data transmission, significantly reducing data transmission time. FastCAPs and ECAPs were measured across five electrodes and four stimulation levels per electrode. The FastCAP stimulation rate (33.3 Hz) is also faster than the ECAP rate (2.5 Hz). Results: Results showed strong correlations between ECAPs and FastCAPs for N1 latency ( Conclusion: This preliminary evaluation suggests that the FastCAP could be an effective clinical tool to optimize CI processor settings (e.g., threshold stimulation levels) in users of the Nurotron CI device.

Indexed as

cochlear implantcomfortable loudness levelelectrically evoked compound action potentialNurotronthreshold level

Identifiers

PMID39840009
PMCPMC11748202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.